Evidence map›Paper›PMID 35925106›Full record

ReviewUrologie (Heidelberg, Germany)2022

[Nephrolithiasis and nephrocalcinosis in children and adolescents].

Bernd Hoppe, Cristina Martin-Higueras, Nina Younsi, Raimund Stein

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in Urologie (Heidelberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05862207 (Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital), which is not on this map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05862207 unknown statusnot on this mapstarted 2023, after this paper: background citation

Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital

TypeobservationalSponsorSohag UniversityRan2023 to 2024Enrolled50ConditionsNephrocalcinosis
3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Bernd HoppeKindernierenzentrum Bonn, Deutsches Hyperoxaluriezentrum, Im Mühlenbach 2b, 53127, Bonn, Deutschland. Bhoppe@hyperoxaluria-center.com.
Cristina Martin-HiguerasKindernierenzentrum Bonn, Deutsches Hyperoxaluriezentrum, Im Mühlenbach 2b, 53127, Bonn, Deutschland.
Nina YounsiZentrum für Kinder‑, Jugend- und rekonstruktive Urologie, Universitätsmedizin Mannheim, 68167, Mannheim, Deutschland.
Raimund SteinZentrum für Kinder‑, Jugend- und rekonstruktive Urologie, Universitätsmedizin Mannheim, 68167, Mannheim, Deutschland.
Nierenzentrum Heidelberg · DEHeidelberg University · DEUniversity Hospital Heidelberg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNephro- or urolithiasis is a common disease. The prevalence of the disease is increasing in both pediatric and adult patients. The genomic calculation of prevalence may reveal higher levels than the previous diagnosis rates. Monogenic kidney stone disease has been identified in 30% of pediatric and 10% of adult patients.

objectivesEven if it seems legitimate to assume that there is no specific underlying disease in the case of a one-time stone episode, such a disease must be excluded in the pediatric patient. Therefore, the present study discusses in detail the evaluation and treatment of kidney stones in children.

methodsRepeated analysis of 24 h urine samples, or multiple spot urine samples in infants and young children, usually provides evidence of the underlying pathology. In addition, any stone removed should be analyzed. These findings are followed by directed genetic diagnostics. Ultrasonography is the preferred diagnostic method. For symptomatic stones, a minimally invasive method of stone removal is chosen if possible, but not every stone needs to be removed. Family workup must be performed, when a specific diagnosis is made in an index case.

conclusionEarly diagnosis is important to avoid recurrences despite the few treatment options available. Delayed diagnosis can have catastrophic consequences for patients (e.g., renal failure). Standard treatment with hyperhydration and alkali citrate treatment alone often helps prevent recurrences. New therapeutic options give hope that stone diseases will become more treatable. Finally, early diagnosis often avoids problematic courses.

Indexed as

Kidney CalculiNephrocalcinosisUrolithiasisAdolescentAlkaliesChildChild, PreschoolCitratesHumansInfantAlkaliesCitratesGeneticsMinimally invasive stone removal proceduresNephrocalcinosisPreventive treatment

Identifiers

PMID35925106
OpenAlexW4284977603

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.